New immune cell therapy benefits laboratory models of ALS and has some positive results in an individual with the disease Post author: Post published:July 11, 2024 Post category:News Feed Post comments:0 Comments The study provides the basis for a phase I clinical trial in additional participants. You Might Also Like Clarifying the cellular mechanisms underlying periodontitis with an improved animal model May 21, 2024 New study analyzes link between digit ratio and oxygen consumption in footballers February 20, 2024 Multiple myeloma: Early detection of aggressive tumors July 2, 2024 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.
Clarifying the cellular mechanisms underlying periodontitis with an improved animal model May 21, 2024